Advertisement
U.S. Markets closed

Avenue Therapeutics, Inc. (ATXI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.0000-0.1100 (-5.21%)
At close: 04:00PM EDT
2.0101 +0.01 (+0.50%)
After hours: 07:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.02M
Enterprise Value -1.90M
Trailing P/E 0.06
Forward P/E 17.99
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.63
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.17
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 345.0000
52 Week Low 31.7000
50-Day Moving Average 32.5007
200-Day Moving Average 36.3842

Share Statistics

Avg Vol (3 month) 348.09k
Avg Vol (10 day) 348.05k
Shares Outstanding 51.43M
Implied Shares Outstanding 6N/A
Float 81.29M
% Held by Insiders 113.16%
% Held by Institutions 18.90%
Shares Short (Sep 30, 2024) 431.54k
Short Ratio (Sep 30, 2024) 41.14
Short % of Float (Sep 30, 2024) 42.20%
Short % of Shares Outstanding (Sep 30, 2024) 42.20%
Shares Short (prior month Aug 30, 2024) 436.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-201.34%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-14.68M
Diluted EPS (ttm)37.4800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.92M
Total Cash Per Share (mrq)3.44
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.30
Book Value Per Share (mrq)4.00

Cash Flow Statement

Operating Cash Flow (ttm)-8.59M
Levered Free Cash Flow (ttm)-13.07M